leninismin elämä poikkeavat free light chain serum kappa dimers Rohkea sitoumus Kääntää
Edgar V. Lerma 🇵🇭 on X: "Serum Free Light Chain Test for Monoclonal Gammopathy #Nephpearls https://t.co/2tcoDessPu http://t.co/O32qFJH9AD" / X
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent | Semantic Scholar
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
Is accuracy of serum free light chain measurement achievable?
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Recombinant Free Light Chains | Absolute Antibody
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift
A method to obtain purified free light chain monomers and dimers from urine samples of patients with multiple myeloma | Immunologic Research
Frontiers | CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Serum and tissue light-chains as disease biomarkers and targets for treatment in AL amyloidosis
Immunoglobulin light chain - Wikipedia
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014